3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development
Multimodality 3D Optical Imaging (OI)/CT has the potential to play a major role in drug development for glioblastomas (GBM), as it is an accessible preclinical method. To demonstrate the potential of 3D OI/CT to visualize orthotopic GBM implantation, we labeled GBM cells with Cy7 and imaged their lo...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Buch |
Veröffentlicht: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Schlagworte: | |
Online-Zugang: | Connect to this object online. |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!